Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
Lorrain DS, Schaffhauser H, Campbell UC, Baccei CS, Correa LD, Rowe B, Rodriguez DE, Anderson JJ, Varney MA, Pinkerton AB, Vernier JM, Bristow LJ. Lorrain DS, et al. Among authors: vernier jm. Neuropsychopharmacology. 2003 Sep;28(9):1622-32. doi: 10.1038/sj.npp.1300238. Epub 2003 Jun 25. Neuropsychopharmacology. 2003. PMID: 12825094
The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents.
Lloyd GK, Menzaghi F, Bontempi B, Suto C, Siegel R, Akong M, Stauderman K, Velicelebi G, Johnson E, Harpold MM, Rao TS, Sacaan AI, Chavez-Noriega LE, Washburn MS, Vernier JM, Cosford ND, McDonald LA. Lloyd GK, et al. Among authors: vernier jm. Life Sci. 1998;62(17-18):1601-6. doi: 10.1016/s0024-3205(98)00114-3. Life Sci. 1998. PMID: 9585143 Review.
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors.
Vernier JM, El-Abdellaoui H, Holsenback H, Cosford ND, Bleicher L, Barker G, Bontempi B, Chavez-Noriega L, Menzaghi F, Rao TS, Reid R, Sacaan AI, Suto C, Washburn M, Lloyd GK, McDonald IA. Vernier JM, et al. J Med Chem. 1999 May 20;42(10):1684-6. doi: 10.1021/jm990035d. J Med Chem. 1999. PMID: 10346920 No abstract available.
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.
Cosford ND, Bleicher L, Herbaut A, McCallum JS, Vernier JM, Dawson H, Whitten JP, Adams P, Chavez-Noriega L, Correa LD, Crona JH, Mahaffy LS, Menzaghi F, Rao TS, Reid R, Sacaan AI, Santori E, Stauderman KA, Whelan K, Lloyd GK, McDonald IA. Cosford ND, et al. Among authors: vernier jm. J Med Chem. 1996 Aug 16;39(17):3235-7. doi: 10.1021/jm960328w. J Med Chem. 1996. PMID: 8765504 No abstract available.
Conformationally restricted analogues of nicotine and anabasine.
Vernier JM, Holsenback H, Cosford ND, Whitten JP, Menzaghi F, Reid R, Rao TS, Sacaan AI, Lloyd GK, Suto CM, Chavez-Noriega LE, Washburn MS, Urrutia A, McDonald IA. Vernier JM, et al. Bioorg Med Chem Lett. 1998 Aug 18;8(16):2173-8. doi: 10.1016/s0960-894x(98)00394-1. Bioorg Med Chem Lett. 1998. PMID: 9873508
41 results